None
Quote | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
Last: | $5.87 |
---|---|
Change Percent: | -0.17% |
Open: | $5.77 |
Close: | $5.87 |
High: | $5.95 |
Low: | $5.745 |
Volume: | 1,046,902 |
Last Trade Date Time: | 12/26/2023 03:00:00 am |
News | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
Novel 505(b)(2) presentation of a key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma, does not require reconstitution, dilution, or refrigeration Amneal plans to launch two to three branded oncology 505(b)(2) products per year going forw...
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its first quarter 2024 financial results on Friday, May 3, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. Th...
Message Board Posts | Amneal Pharmaceuticals Inc. Class A (NYSE:AMRX)
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining | dangerx | investorshub | 07/02/2023 10:42:27 PM |
best news of the day | ListenToMe | investorshub | 07/01/2023 1:35:40 PM |
$AMRX Price gaining | Elpapibh | investorshub | 06/29/2023 8:17:43 PM |
$AMRX MomentumIts now last trade up | ClayTrader | investorshub | 06/28/2023 2:43:21 PM |
$AMRX The gaining | ListenToMe | investorshub | 06/27/2023 2:57:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Amneal Pharmaceuticals Inc. Class A Company Name:
AMRX Stock Symbol:
NYSE Market:
Novel 505(b)(2) presentation of a key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma, does not require reconstitution, dilution, or refrigeration Amneal plans to launch two to three branded oncology 505(b)(2) products per year going forw...
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its first quarter 2024 financial results on Friday, May 3, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. Th...
- Celebrating Amneal’s recent listing on the Nasdaq Stock Exchange Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced that Chirag and Chintu Patel, Co-founders and Co-Chief Execut...